Indicated Prevention With At-Risk Gamblers

This study has been completed.
Sponsor:
Information provided by:
National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier:
NCT00078273
First received: February 20, 2004
Last updated: September 19, 2008
Last verified: September 2008
  Purpose

The overall purpose of this study is to reduce the prevalence of gambling risk in college students by evaluating the effectiveness of different treatments in reducing gambling behavior and related negative consequences.


Condition Intervention Phase
Gambling
Behavioral: Brief Personal Feedback Intervention
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Indicated Prevention With At-Risk Gamblers

Resource links provided by NLM:


Further study details as provided by National Institute of Mental Health (NIMH):

Estimated Enrollment: 225
Study Start Date: July 2003
Estimated Study Completion Date: June 2006
Detailed Description:

Participants in this study will be randomly assigned to a personal feedback intervention (PFI) or assessment only for 3 years. The PFI intervention will be delivered in a single session. Measures will include the NORC DSM Screen for Problem Gambling (NODS), the South Oaks Gambling Screen (SOGS), Gambling Quantity and Perceived Norms, Perceived Injunctive Gambling Norms, Gambling Problems Index, gambling frequency, attitudes and beliefs about gambling and self-control, readiness to change, gambling expectancies, gambling motives, gambling risk perception, psychiatric symptoms, assertiveness, coping skills, substance use, alcohol-related problems, self-determination, and social desirability.

  Eligibility

Ages Eligible for Study:   17 Years to 24 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • College student
  • South Oaks Gambling Screen (SOGS) score greater than 3
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00078273

Locations
United States, Washington
University of Washington; Department of Psychiatry and Behavioral Sciences
Seattle, Washington, United States, 98195
Sponsors and Collaborators
  More Information

No publications provided by National Institute of Mental Health (NIMH)

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00078273     History of Changes
Other Study ID Numbers: R21 MH67026, DATR A2-AII
Study First Received: February 20, 2004
Last Updated: September 19, 2008
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Gambling
Impulse Control Disorders
Mental Disorders

ClinicalTrials.gov processed this record on May 19, 2013